Arcus Capital Partners’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
Arcus Capital Partners's EXEL Position: Q1 2026 in Review
Arcus Capital Partners reduced its Exelixis (EXEL) stake by 22% in Q1 2026, selling an estimated $71.2K and leaving 5,876 shares worth $252K. The position accounts for 0.09% of the portfolio, ranked #101.
Arcus Capital Partners first reported a position in EXEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $330K in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Arcus Capital Partners held 5,876 shares of Exelixis worth $252K as of Q1 2026.
- Arcus Capital Partners sold 1,657 Exelixis shares in Q1 2026, an estimated $71.2K.
- Exelixis made up 0.09% of Arcus Capital Partners's portfolio in Q1 2026, its #101 holding.
- Arcus Capital Partners first reported a position in Exelixis in Q3 2025 and has held it in 3 quarters since.
- Arcus Capital Partners's Exelixis position peaked at $330K in Q4 2025.
- 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Arcus Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.